2007;5:10. 45. Wen PY, et al. Updated response assessment criteria for high-grade gliomas: response assess- ment in neuro-oncology working group. J Clin Oncol . 2010;28(11):1963–1972. 46. Chen AP, et al. Grading dermatologic adverse events of cancer treatments: the common termi-nology criteria for adverse events version 4.0. J Am Acad Dermatol. 2012;67(5):1025–1039. 47 . Chen H, Lau MC, Wong MT, Newell EW, Poidinger M, Chen J. Cytofkit: a Bioconductor package for an Integrated Mass cytometry data analysis pipeline. PLoS Comput Biol. 2016;12(9):e1005112. 48. Bailey S, et al. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer .